Log in

Relevant bibliographies by topics / Infections à Acinetobacter – Chimiothérapie / Journal articles

To see the other types of publications on this topic, follow the link: Infections à Acinetobacter – Chimiothérapie.

Journal articles on the topic 'Infections à Acinetobacter – Chimiothérapie'

Author: Grafiati

Published: 15 June 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Infections à Acinetobacter – Chimiothérapie.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Wilson, Brigid M., Federico Perez, Qing Pan, Yunyun Jiang, Scott R. Evans, and Robert A. Bonomo. "Acinetobacter Infections." Clinical Infectious Diseases 71, no. 5 (2019): 1357–58. http://dx.doi.org/10.1093/cid/ciz1099.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Snoeck, R., and E. De Clercq. "La chimiothérapie des infections a cytomégalovirus." Médecine et Maladies Infectieuses 18 (March 1988): 79–84. http://dx.doi.org/10.1016/s0399-077x(88)80102-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kempf, M. "Infections à Acinetobacter." EMC - Maladies infectieuses 34, no. 4 (2017): 1–6. https://doi.org/10.1016/s1166-8598(17)73722-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Özgür, Özlem, and Necmi Aksaray. "Acinetobacter Infections and Treatment." Journal of Pediatric Infection 8, no. 1 (2014): 28–32. http://dx.doi.org/10.5152/ced.2013.38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Joly-Guillou, M. L. "Acinetobacter et infections nosocomiales." Revue Française des Laboratoires 2002, no. 345 (2002): 14. http://dx.doi.org/10.1016/s0338-9898(02)80247-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Falagas, M. E., E. A. Karveli, I. Kelesidis, and T. Kelesidis. "Community-acquired Acinetobacter infections." European Journal of Clinical Microbiology & Infectious Diseases 26, no. 12 (2007): 857–68. http://dx.doi.org/10.1007/s10096-007-0365-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Garnacho-Montero, José, and Jean-François Timsit. "Managing Acinetobacter baumannii infections." Current Opinion in Infectious Diseases 32, no. 1 (2019): 69–76. http://dx.doi.org/10.1097/qco.0000000000000518.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bergogne-Bérézin, E. "Treatment of Acinetobacter infections." Expert Opinion on Investigational Drugs 6, no. 2 (1997): 119–27. http://dx.doi.org/10.1517/13543784.6.2.119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gaifer, Zied, Raneem Fallatah, Alhanouf Alanazi, Raghad Alfagi, Lina Alharbi, and Haitham Osman. "Prevalence, Risk Factors, and Outcome of Carbapenem-resistant Acinetobacter Infections in a Community Hospital in Madinah, Saudi Arabia." Saudi Journal of Medicine & Medical Sciences 12, no. 4 (2024): 306–13. http://dx.doi.org/10.4103/sjmms.sjmms_582_23.

Full text

Abstract:

Abstract Background: Acinetobacter is a Gram-negative bacterium that causes nosocomial infections, increasing healthcare costs, patient morbidity, and mortality. The rate of carbapenem resistance among Acinetobacter species is rising in several countries, including Saudi Arabia. Objective: To determine the risk factors and compare the predictors of mortality in patients infected with carbapenem-susceptible and carbapenem-resistant Acinetobacter strains. Materials and Methods: This retrospective study included patients with Acinetobacter infection who were admitted to a community hospital in Ma

APA, Harvard, Vancouver, ISO, and other styles

10

Miah, Md Ruhul Amin. "Acinetobacter baumannii Hospital Acquired Infections." Bangladesh Journal of Medical Microbiology 13, no. 1 (2019): 1–3. http://dx.doi.org/10.3329/bjmm.v13i1.51778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Fleming, Irma D., Monika A. Krezalek, Natalia Belogortseva, et al. "Modeling Acinetobacter baumannii wound infections." Journal of Trauma and Acute Care Surgery 82, no. 3 (2017): 557–65. http://dx.doi.org/10.1097/ta.0000000000001338.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Levin, Anna S. "Treatment of Acinetobacter spp. infections." Expert Opinion on Pharmacotherapy 4, no. 8 (2003): 1289–96. http://dx.doi.org/10.1517/14656566.4.8.1289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Abbott, Iain J., and Anton Y. Peleg. "Acinetobacter baumannii and hospital infections." Microbiology Australia 35, no. 1 (2014): 54. http://dx.doi.org/10.1071/ma14015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

HIRAKATA, Yoichi. "Acinetobacter spp. Infections." Kansenshogaku Zasshi 85, no. 4 (2011): 340–46. http://dx.doi.org/10.11150/kansenshogakuzasshi.85.340.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

de Benedictis, Fernando Maria, Patrizia Osimani, and Carmelo Gabriele. "Acinetobacter baumannii infections in children." Lancet Infectious Diseases 10, no. 3 (2010): 143–44. http://dx.doi.org/10.1016/s1473-3099(10)70030-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Grundmann, H. "Acinetobacter; microbiology, epidemiology, infections, management." Journal of Hospital Infection 40, no. 1 (1998): 83. http://dx.doi.org/10.1016/s0195-6701(98)90031-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Joly-Guillou, M. L., J. P. Sollet, C. Varache, and E. Bergogne-Berezin. "Infections dues à Acinetobacter baumannii." Médecine et Maladies Infectieuses 23 (October 1993): 67–72. http://dx.doi.org/10.1016/s0399-077x(05)80517-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bergogne-Bérézin, E. "Acinetobacter infections: Unusual infection sites." Antibiotiques 10, no. 2 (2008): 81–87. http://dx.doi.org/10.1016/j.antib.2007.12.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Salmanov, A. G., O. M. Verner, and L. F. Slepova. "Epidemiology and antimicrobial resistance of Acinetobacter." International Journal of Antibiotics and Probiotics 2, no. 4 (2018): 46–59. http://dx.doi.org/10.31405/ijap.4-5.18.05.

Full text

Abstract:

Species of the Acinetobacter represent opportunistic bacteria with a growing clinical significance for Healthcare-associated infections (HAIs). In this literature review, we focus on the current role of Acinetobacter in infectious pathology and describe taxonomy, pathogenicity, and antibiotic resistance of these bacteria. Pathogenesis and regulation of virulence factors in Acinetobacter spp. are described in detail. The majority of acinetobacterial infections are associated with A. baumannii and occur predominantly in an immunocompromised host. Usually, acinetobacterial infections are characte

APA, Harvard, Vancouver, ISO, and other styles

20

Baral, Shankar, Anjila Pokharel, Supram Hosuru Subramanya, and Niranjan Nayak. "Clinico-epidemiological profile of Acinetobacter and Pseudomonas infections, and their antibiotic resistant pattern in a tertiary care center, Western Nepal." Nepal Journal of Epidemiology 9, no. 4 (2019): 804–11. http://dx.doi.org/10.3126/nje.v9i4.26962.

Full text

Abstract:

Background: Infections caused by Acinetobacter species and Pseudomonas species, especially multidrug-resistant (MDR) strains pose a serious management challenge with a public health threat. Materials and Methods: A hospital-based retrospective study of patients who were infected with Acinetobacter spp or Pseudomonas aeruginosa was carried out at Manipal Teaching Hospital from 2014 to 2016. Results: A total of 170 cases of infections with Acinetobacter spp. and 313 cases with Pseudomonas aeruginosa were studied. The rate of nosocomial infections was higher than non-nosocomial infect

APA, Harvard, Vancouver, ISO, and other styles

21

Ingrand, Didier. "Chimiothérapie des infections à CMV et résistance aux antiviraux." Revue Française des Laboratoires 2002, no. 345 (2002): 57–62. http://dx.doi.org/10.1016/s0338-9898(02)80266-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Huang, Chienhsiu, Lichen Lin, and Sufang Kuo. "Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant Acinetobacter baumannii Infections—A Meta-Analysis." Antibiotics 13, no. 9 (2024): 907. http://dx.doi.org/10.3390/antibiotics13090907.

Full text

Abstract:

The addition of sulbactam restores the complete range of cefoperazone activity against bacteria and extends its spectrum of action to include the Acinetobacter species. The effectiveness of cefoperazone/sulbactam against multiresistant Acinetobacter baumannii has not been investigated. The purpose of the current meta-analysis was to compare the efficacy of cefoperazone/sulbactam-based therapeutic regimens and non-cefoperazone/sulbactam-based therapeutic regimens in the treatment of multiresistant Acinetobacter baumannii infections. The current meta-analysis of 10 retrospective studies provides

APA, Harvard, Vancouver, ISO, and other styles

23

H., Sanjeev, Swathi N., Asha Pai, Rekha R., Vimal K., and Ganesh H. R. "SYSTEMATIC REVIEW OF URINARY TRACT INFECTION CAUSED BY ACINETOBACTER SPECIES AMONG HOSPITALISED PATIENTS." Journal of Health and Allied Sciences NU 03, no. 04 (2013): 007–9. http://dx.doi.org/10.1055/s-0040-1703693.

Full text

Abstract:

Abstract Introduction:Acinetobacter species have emerged as important nosocomial pathogens and have been known to cause different kinds of opportunistic infections. Acinetobacter species cause a wide variety of illness in debilitated and hospitalized patients especially in intensive care units (ICU). Because of frequent resistance to aminoglycoside's, fluoroquinolone's, ureidopenicillin's and third generation cephalosporin's, carbapenem are important agents in managing Acinetobacter infections. Material and Methods: A systematic retrospective analysis was performed on culture positive urinary

APA, Harvard, Vancouver, ISO, and other styles

24

PORTER, K. A., J. RHODES, S. DEJSIRILERT, et al. "Acinetobacter bacteraemia in Thailand: evidence for infections outside the hospital setting." Epidemiology and Infection 142, no. 6 (2013): 1317–27. http://dx.doi.org/10.1017/s0950268813002082.

Full text

Abstract:

SUMMARYAcinetobacter is a well-recognized nosocomial pathogen. Previous reports of community-associated Acinetobacter infections have lacked clear case definitions and assessment of healthcare-associated (HCA) risk factors. We identified Acinetobacter bacteraemia cases from blood cultures obtained <3 days after hospitalization in rural Thailand and performed medical record reviews to assess HCA risk factors in the previous year and compare clinical and microbiological characteristics between cases with and without HCA risk factors. Of 72 Acinetobacter cases, 32 (44%) had no HCA risk factors

APA, Harvard, Vancouver, ISO, and other styles

25

Brandão, Rafael Augusto Castro Santiago, Moises Heleno Vieira Braga, Lucas Alverne Freitas De Albuquerque, Paulo Pereira Christo, Marcello Penholate Faria, and Baltazar Leão Reis. "Multiresistant Acinetobacter baumannii ventriculitis." JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA 23, no. 2 (2018): 172–75. http://dx.doi.org/10.22290/jbnc.v23i2.1173.

Full text

Abstract:

Among Gram-negative bacteria, Acinetobacter sp. has become an important nosocomial pathogen due to the increase in the number of multiresistant strains, and this species is responsible for a growing number of postoperative infections with a high mortality rate. The occurrence of multiresistant Gram-negative bacteria has led to an increase in the number of central nervous system infections and the occurrence of bacteria resistant to fourth-generation cephalosporins and carbapenems resulted in a significant reduction of therapeutic options for the treatment of these infections. Acinetobacter bau

APA, Harvard, Vancouver, ISO, and other styles

26

Baliga, Shrikala, Prerna Khurana, Suchitra Shenoy, and Prasanna Mithra. "A RISING THREAT – RISK FACTORS AND OUTCOMES RELATED TO INFECTIONS WITH ACINETOBACTER SPECIES." Asian Journal of Pharmaceutical and Clinical Research 10, no. 3 (2017): 108. http://dx.doi.org/10.22159/ajpcr.2017.v10i3.15364.

Full text

Abstract:

ABSTRACTObjective: Acinetobacter species is an important cause of community as well as nosocomial infections with a high mortality rate. The study was doneto analyze the risk factors associated with Acinetobacter infections and their outcomes.Methods: The clinical details of 100 patients having infections with Acinetobacter species over a period of 1-year were analyzed for underlying riskfactors and outcomes. The antibiotic sensitivity results were interpreted according to the Clinical Laboratory Standards Institute guidelines.Results: Majority of the infections caused by the Acinetobacter spe

APA, Harvard, Vancouver, ISO, and other styles

27

Khawaja, Aneela, Faiqa Arshad, and Sadaf Aleem. "ACINETOBACTER SPECIES." Professional Medical Journal 25, no. 12 (2018): 1949–53. http://dx.doi.org/10.29309/tpmj/18.4723.

Full text

Abstract:

Introduction: The genetic competencies of bacteria and the resistance have been impeding the usefulness of antibiotic therapy. There has been an alarming increase in the infections caused by Acinetobacter spp. especially the multidrug resistance pattern has narrowed the therapeutic ranges. Objectives: To determine the prevalence and antibiotic sensitivity pattern of Acinetobacter spp., among clinical specimens of tertiary care hospital.Study Design: Descriptive study. Place & Duration of Study: Pathology Department, PGMI, from January 2015 to December 2015. Materials & Methods: Total 8

APA, Harvard, Vancouver, ISO, and other styles

28

Ali, Sana. "Acinetobacter infections: Overview and treatment dilemma." CHRISMED Journal of Health and Research 7, no. 1 (2020): 30. http://dx.doi.org/10.4103/cjhr.cjhr_30_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Rello, Jordi. "Acinetobacter baumannii Infections in the ICU." Chest 115, no. 5 (1999): 1226–29. http://dx.doi.org/10.1378/chest.115.5.1226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Kucukler, E. "Risk factors of Acinetobacter baumannii infections." International Journal of Infectious Diseases 21 (April 2014): 420. http://dx.doi.org/10.1016/j.ijid.2014.03.1287.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Palkovsky, O. L., L. I. Novogran, and I. O. Polonskaya. "PROBLEMS OF THERAPY OF nosocomial infections caused by <i>ACINETOBACTER BAUMANNII</i> (literature review)." Health and Ecology Issues, no. 3 (September 28, 2014): 26–30. http://dx.doi.org/10.51523/2708-6011.2014-11-3-4.

Full text

Abstract:

The microorganism Acinetobacter baumannii is a common cause of nosocomial infections, particularly in wards of resuscitation and intensive care. The problem of treatment for these infections is the extremely good resistance of the microorganism to antimicrobial agents. The present article deals with the problems of epidemiology and rational antimicrobial therapy for infections caused by Acinetobacter baumannii.

APA, Harvard, Vancouver, ISO, and other styles

32

Qian, Zhenhua, Shufang Zhang, Na Li, et al. "Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections." BioMed Research International 2022 (February 27, 2022): 1–10. http://dx.doi.org/10.1155/2022/5122085.

Full text

Abstract:

Background. Although the clinical features of Acinetobacter baumannii bloodstream infection are well described, the specific clinical characteristics of polymicrobial Acinetobacter baumannii bloodstream infection have been rarely reported. The objective of this study was to examine the risk factors for and clinical outcomes of polymicrobial Acinetobacter baumannii bloodstream infection. Methods. A retrospective observational study was performed from January 2013 to December 2018 in a tertiary hospital. All patients with Acinetobacter baumannii bloodstream infection were enrolled, and the data

APA, Harvard, Vancouver, ISO, and other styles

33

A. Tantawy, Enas, Hanan M. El-Sayed, Heba M. Matar, and Basma A. El-Azhary. "Multi- and Extensive-Drug Resistant Acinetobacter baumannii in ICUs: Risk Factors, Antimicrobial Resistance Profiles and co-harboring of gyrA and parC mutations." Egyptian Journal of Medical Microbiology EJMM29, no. 4 (2020): 109–16. http://dx.doi.org/10.51429/ejmm29414.

Full text

Abstract:

Background: Acinetobacter baumannii is a gram-negative organism that is implicated in hospital acquired infections. It confers high resistance to many classes of antibiotics. Objectives: To assess the prevalence of multi and extensive drug-resistant (MDR & XDR) Acinetobacter baumannii, their risk factors, antimicrobial resistance patterns and the presence of gyrA and parC gene mutations of quinolone resistance. Methodology: The study included 106 ICU patients (56 males & 50 females), samples were collected according to sites of infections, Acinetobacter baumannii was identified by morp

APA, Harvard, Vancouver, ISO, and other styles

34

Khalilov, R., M. Mammadova, and Sh Abdullayeva. "Mechanism of resistance to beta-lactam antibiotics." BULLETIN of the L.N. Gumilyov Eurasian National University. BIOSCIENCE Series 143, no. 3 (2023): 115–27. http://dx.doi.org/10.32523/2616-7034-2023-144-3-115-127.

Full text

Abstract:

Acinetobacter baumannii is the most commonly associated human pathogen with infections in the genus. This opportunistic pathogen causes quite serious infections, especially in fond patients, and has the ability to quickly develop resistance to new antibiotics. In the recent past, carbapenems, a. It was the first option in the treatment of Baumannii infections. But recently there have been many clinics Acinetobacter the baumannii isolate has acquired resistance to all conventional antibiotics, including carbapenems. This compilation is Acinetobacter it can refresh our knowledge about the resist

APA, Harvard, Vancouver, ISO, and other styles

35

Bhat, Sevitha, and Sridevi Shridhar. "CLINICOMICROBIOLOGICAL STUDY OF INFECTIONS CAUSED BY ACINETOBACTER SPECIES." Asian Journal of Pharmaceutical and Clinical Research 10, no. 4 (2017): 223. http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16596.

Full text

Abstract:

To study the rate of isolation of Acinetobacter species, its antibiogram and associated risk factors.Materials and Methods:Retrospective time bound study for a period of 6 months. The study included 191 consecutive clinical significant isolates of Acinetobacter species isolated from various specimens. The identification and antibiotic susceptibility testing by modified Kirby Bauer and Vitek Compact system 2.Results and Discussion:Maximum isolation of Acinetobacter species was from Suction Tip (31.94%), sputum (19.89%), urine (14.66%), blood (10.47%) and others. The species was most sensitive t

APA, Harvard, Vancouver, ISO, and other styles

36

Prisacari, Viorel. "The problem of methicillin-resistant Staphylococcus and Acinetobacter nosocomial infections (Literature review)." Akademos, no. 1(68) (June 2023): 33–41. http://dx.doi.org/10.52673/18570461.23.1-68.03.

Full text

Abstract:

Sosocomial septic infections continue to remain one of the leading causes of mortality in hospital wards. In this context, nosocomial infections caused by novel aetiological agents of the Staphylococcus and Acinetobacter genera are a current problem. The article presents relevant data on the topic of the spread of nosocomial infections with methicillin-resistant Staphylococcus and Acinetobacter worldwide, as well as the situation regarding the spread of these infections in the Republic of Moldova.

APA, Harvard, Vancouver, ISO, and other styles

37

Kuhrau, Shannon. "894 Three Year Acinetobacter Spp. Infection Patterns in the Burn Intensive Care Unit." Journal of Burn Care & Research 46, Supplement_1 (2025): S323. https://doi.org/10.1093/jbcr/iraf019.425.

Full text

Abstract:

Abstract Introduction Patients with burns are at high risk of developing multi-drug resistant organisms which can contribute to poor wound healing, longer hospital lengths of stay, and mortality. Acinetobacter spp. infections can develop in this patient population and are often associated with some type of resistance leading to difficulties in treatment. The purpose of this study is to describe the characteristics, resistance patterns and eventual antibiotic selection in this difficult-to-treat infection in the burn population. Methods Retrospective chart review of patients with Acinetobacter

APA, Harvard, Vancouver, ISO, and other styles

38

Elham, Bukhari, and Alotaibi Fawzia. "Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome." African Health Sciences 19, no. 3 (2019): 2400–2406. http://dx.doi.org/10.4314/ahs.v19i3.13.

Full text

Abstract:

Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant organism due to the rising number of associated nosocomial infections. The therapeutic options are extremely minimal because of its ability to develop resistance to all available antimicrobials, including colistin (CST). Data on the clinical and microbiological characteristics of colistin-resistant A. baumannii infections remain scarce to date.Methods: In this prospective study, clinical isolates of colistin resistance among Acinetobacter strain was evaluated from the database of Microbiology Laboratory of

APA, Harvard, Vancouver, ISO, and other styles

39

Dr., Venugopal Reddy. I; Dr. Rajesh Babu. M; Dr. Bhaskar Shenoy. "Clinical Spectrum and Antibiogram of Acinetobacter Infections in Children: Study from a Tertiary Care Centre, India." International Journal of Innovative Science and Research Technology 8, no. 4 (2023): 1201–12. https://doi.org/10.5281/zenodo.7889065.

Full text

Abstract:

Acinetobacter is an aerobic, pleomorphic, non-motile bacillus that is Gram-negative. In the last 35 years, Acinetobacter baumannii has emerged as the most problematic bacterium in the hospital and community due to its genetic makeup and antibiotic resistance. Infections of the skin, soft tissues, central nervous system, and bones are on the rise due to strains that are resistant to antibiotics and can survive for a long period. This study aims to study the epidemiological and clinical characteristics and antibiogram of different species of Acinetobacter. Antimicrobial susceptibility testing wa

APA, Harvard, Vancouver, ISO, and other styles

40

Wisplinghoff, Hilmar, Tobias Paulus, Marianne Lugenheim, et al. "Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States." Journal of Infection 64, no. 3 (2012): 282–90. http://dx.doi.org/10.1016/j.jinf.2011.12.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Saha, Swarnatrisha, Ksh Mamta Devi, Shan Damrolien, and Kh Sulochana Devi. "A study of Acinetobacter infections in a tertiary care hospital in Northeast India." International Journal of Research in Medical Sciences 6, no. 6 (2018): 2076. http://dx.doi.org/10.18203/2320-6012.ijrms20182292.

Full text

Abstract:

Background: Acinetobacter is an important opportunistic pathogen and is a common cause of hospital acquired infections. Acinetobacter infections are often extremely difficult to treat because of their widespread resistance to the major groups of antibiotics. The study was conducted to determine prevalence and antibiotic susceptibility pattern of Acinetobacter species isolated from various clinical samples.Methods: Clinical specimens over a period of 2yrs from May 2015 to April 2017 were collected from the patients attending the hospital. Acinetobacter species isolates were identified, and anti

APA, Harvard, Vancouver, ISO, and other styles

42

Benga, Laurentiu, Andrea T. Feßler, W. Peter M. Benten, et al. "Acinetobacter species in laboratory mice: species survey and antimicrobial resistance." Laboratory Animals 53, no. 5 (2018): 470–77. http://dx.doi.org/10.1177/0023677218818598.

Full text

Abstract:

The extra-hospital epidemiology of Acinetobacter infections is a subject of debate. In recent years, the prevalence of animal multidrug-resistant Acinetobacter infections has increased considerably. The goal of the present study was to specify Acinetobacter species isolated from laboratory mice and to test them for their antimicrobial susceptibility. During routine microbiological monitoring of laboratory mice, 12 Acinetobacter spp. were isolated. By means of 16S rRNA and rpoB gene sequencing, seven of the isolates were identified as Acinetobacter radioresistens, three isolates belonged to Aci

APA, Harvard, Vancouver, ISO, and other styles

43

Nath, Shubhra Kanti Dev, and Md Mizanur Rahman. "Isolation of Acinetobacter Species from Wound Infection and Their Antimicrobial Resistance Pattern in a Tertiary Care Hospital in Rajshahi, Bangladesh." Saudi Journal of Pathology and Microbiology 7, no. 3 (2022): 162–64. http://dx.doi.org/10.36348/sjpm.2022.v07i03.015.

Full text

Abstract:

Background: Acinetobacter species has emerged as an important pathogen globally in various infections especially in hospital acquired infections. Objectives: This study was conducted to determine the antibiotic resistance pattern of Acinetobacter species from wound swab samples. Materials and Methods: A Cross sectional study was undertaken in Department of Microbiology, Rajshahi Medical College (RMC), Rajshahi, Bangladesh from period January 2014 to December 2014. A total 13 Acinetobacter were collected from 292 wound infection patients of surgery word and its allied brances in Rajshahi medica

APA, Harvard, Vancouver, ISO, and other styles

44

Sharmin, Rizwana, SM Shamsuzzaman, Faruk Hossain, et al. "Prevalence and Antibiotic Resistance Pattern among Acinetobacter baumannii Isolated from Patients at Dhaka Medical College Hospital." Journal of Comilla Medical College Teachers' Association 29, no. 1 (2025): 15–19. https://doi.org/10.3329/jcomcta.v29i1.81461.

Full text

Abstract:

Background: Acinetobacter baumannii causes serious nosocomial infections, and is associated with high morbidity and mortality. Objective: The objective of this study was to determine the prevalence of Acinetobacter baumanii infection in patients at Dhaka Medical College Hospital and to estimate antimicrobial resistance pattern among the Acinetobacter baumannii isolates. Method: During the study period from January 2022 to December 2022, 400 clinical samples, including endotracheal aspirates, wound swab and pus, blood, sputum, urine were collected and analyzed from patients admitted and visitin

APA, Harvard, Vancouver, ISO, and other styles

45

Tan, Henny Tannady, Irene Maria Elena, Ade Dharmawan, and Nicolas Layanto. "Unusual Polymicrobial Wound Infections In Healthy Patient After Cesarean Sectio." Jurnal Midpro 12, no. 1 (2020): 1. http://dx.doi.org/10.30736/md.v12i1.151.

Full text

Abstract:

Cesarean delivery often complicated by surgical site infection, wound infection and endometritis. No study mention Multidrug Resistant Klebsiella pneumonia and Acinetobacter lwofii were isolated.Here we report a rare case of polymicrobial wound infections in healthy patient after Cesarean Sectio caused by Pseudomonas aeruginosa, Multidrug Resistant Klebsiella pneumonia and Acinetobacter iwofii. A 30-year-old woman at 37 weeks gestation (G1P0A0) presented to our hospital for cesarean sectio due to oligohydroamnios and malpresentation. She came to us on the eleventh post-delivery day with discha

APA, Harvard, Vancouver, ISO, and other styles

46

Cheng, John ChauFu. "Acinetobacter Baumannii Detection Using A Bio-FET Device: Towards Healthcare Infection Management." ECS Meeting Abstracts MA2023-01, no. 34 (2023): 1913. http://dx.doi.org/10.1149/ma2023-01341913mtgabs.

Full text

Abstract:

Acinetobacter is a group of bacteria commonly found in the environment, like in soil and water. While there are many types, the most common cause of infections is Acinetobacter baumannii, which accounts for most Acinetobacter infections in humans. Acinetobacter baumannii could result in infections in the blood, urinary tract, in wounds of the body or lungs. Traditionally, medical technicians in hospital use the sample from patients (like stool, urine, or sputum) to streak on a plate or do bacteria culture test. It takes too much time and patients cannot wait so long. Therefore, it is vital tha

APA, Harvard, Vancouver, ISO, and other styles

47

Cai, Wei, Dinesh Kumar Kesavan, Jianjun Cheng, et al. "Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response." Journal of Immunology Research 2019 (December 30, 2019): 1–11. http://dx.doi.org/10.1155/2019/2835256.

Full text

Abstract:

Acinetobacter baumannii, as a nonfermentation Gram-negative bacterium, mainly cause nosocomial infections in critically ill patients. With the widespread of multidrug-resistant Acinetobacter baumannii, the urgency of developing effective therapy options has been emphasized nowadays. Outer membrane vesicles derived from bacteria show potential vaccine effects against bacterial infection in recent study. Our present research is aimed at investigating the mechanisms involved in immune protection of mice after outer membrane vesicle immunization. As our data showed, the outer membrane vesicle from

APA, Harvard, Vancouver, ISO, and other styles

48

PRISACARI, Viorel, and Nicoleta ANDRONACHI. "Epidemiological study of Acinetobacter baumannii nosocomial infections." One Health & Risk Management 2, no. 2 (2021): 36–41. http://dx.doi.org/10.38045/ohrm.2021.2.05.

Full text

Abstract:

Introduction. Acinetobacter baumannii is a pathogen and a major cause of nosocomial infections in the current healthcare system worldwide due to its high resistance to antibiotics, including those considered as a last resort, thus posing threat to severe clinical forms, as well as exhibiting significant economic and clinical impact. Material and methods. A descriptive longitudinal and cross-sectional epidemiological study was carried out based on the model of multidisciplinary care hospitals. Results. The generalized clinical forms of Acinetobacter nosocomial infections predominate

APA, Harvard, Vancouver, ISO, and other styles

49

Garnacho-Montero, José, and Rosario Amaya-Villar. "Multiresistant Acinetobacter baumannii infections: epidemiology and management." Current Opinion in Infectious Diseases 23, no. 4 (2010): 332–39. http://dx.doi.org/10.1097/qco.0b013e32833ae38b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Humphreys, H., K. J. Towner, M. Crowe, et al. "Acinetobacter infections, intensive care units, and handwashing." Lancet 345, no. 8942 (1995): 121–23. http://dx.doi.org/10.1016/s0140-6736(95)90086-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!